Security key
928661107
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX)
CUSIP: 928661107
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 159,533,673
- Total 13F shares
- 17,526,713
- Share change
- +9,605,010
- Total reported value
- $10,533,642
- Put/Call ratio
- 0.25%
- Price per share
- $0.60
- Number of holders
- 21
- Value change
- +$5,772,495
- Number of buys
- 9
- Number of sells
- 11
Report period
Q3 2024
Institutions
21
Top holders
10
VNRX full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
VOLITIONRX LTD SEC filings
VOLITIONRX LTD company facts
Broader feeds
Reporting periods
Holder history for CUSIP 928661107
Recent filing periods:
Top shareholders of VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Lagoda Investment Management, L.P. |
13F
|
Company |
3.4%
|
5,438,000
|
$3,289,990 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.4%
|
636,667
|
$385,183 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.4%
|
634,548
|
$383,999 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.32%
|
516,073
|
$312,224 | — | 30 Jun 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
174,180
|
$105,379 | — | 30 Jun 2024 | |
| Silverberg Bernstein Capital Management LLC |
13F
|
Company |
0.09%
|
144,618
|
$87,494 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.08%
|
123,923
|
$74,973 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
89,296
|
$54,024 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.06%
|
89,225
|
$53,981 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
66,932
|
$40,494 | — | 30 Jun 2024 | |
| Ground Swell Capital, LLC |
13F
|
Company |
0.02%
|
25,710
|
$15,555 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
15,484
|
$9,368 | — | 30 Jun 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
14,501
|
$8,773 | — | 30 Jun 2024 | |
| Ashton Thomas Private Wealth, LLC |
13F
|
Company |
0%
|
7,117
|
$4,306 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
6,244
|
$3,778 | — | 30 Jun 2024 | |
| Hartford Financial Management Inc. |
13F
|
Company |
0%
|
5,000
|
$3,025 | — | 30 Jun 2024 | |
| Founders Capital Management |
13F
|
Company |
0%
|
2,000
|
$1,210 | — | 30 Jun 2024 | |
| Redwood Wealth Management Group, LLC |
13F
|
Company |
0%
|
1,000
|
$605 | — | 30 Jun 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
900
|
$549 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
526
|
$318 | — | 30 Jun 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
265
|
$160 | — | 30 Jun 2024 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
200
|
$142 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
150
|
$91 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0%
|
29
|
$18 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
2
|
$2 | — | 30 Jun 2024 | |
| Eight Corp Ltd |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
24,030,664
mixed-class rows
|
$20,785,825 | — | 02 Jan 2024 | |
| Martin Charles Faulkes |
3/4/5
|
Executive Director, Director |
—
class O/S missing
|
2,096,207
|
$1,739,852 | — | 24 Jan 2024 | |
| Edward Futcher |
3/4/5
|
Director |
—
class O/S missing
|
436,436
|
$362,242 | — | 24 Jan 2024 | |
| Jason Bradley Terrell MD |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
33,192
|
$27,550 | — | 03 Aug 2022 | |
| Richard Brudnick |
3/4/5
|
Director |
—
class O/S missing
|
27,936
|
$23,187 | — | 12 Jan 2023 |
Institutional Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q3 2024
As of 30 Sep 2024,
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,526,713 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Lagoda Investment Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock, Inc., Silverberg Bernstein Capital Management LLC, STATE STREET CORP, UBS Group AG, NORTHERN TRUST CORP, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
21
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
25
Q3 2024 holders
21
Holder diff
-4
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.